Home > Income Statement > GENPHARMASEC

GENPHARMASEC
Revenue

    Back to Income Statement
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

GENPHARMASEC Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023
Net Sales ₹30 Cr₹26 Cr₹26 Cr

What is the latest Revenue of GENPHARMASEC ?

The latest Revenue ratio of GENPHARMASEC is ₹30 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹30 Cr
Mar2024₹26 Cr
Mar2023₹26 Cr

How is Revenue of GENPHARMASEC Trending?

Years Revenue % Change
Mar2025 ₹30 Cr
19.16
Mar2024 ₹26 Cr
0.00
Mar2023 ₹26 Cr -

Compare Revenue of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹60.9 Cr 1.9% -17.9% -55.8% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹6,530.3 Cr 4.5% -14.1% -16% Stock Analytics
KIRI INDUSTRIES ₹2,312.4 Cr -0.1% -15.9% -32.5% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,473.4 Cr -2.1% -4.8% -36.4% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹992.6 Cr 2.5% -12.1% 0.7% Stock Analytics
BODAL CHEMICALS ₹545.2 Cr -1.6% -14.7% -22.1% Stock Analytics


GENPHARMASEC Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

1.9%

-17.9%

-55.8%

SENSEX

-5.5%

-11.5%

0.3%


You may also like the below Video Courses